Vapendavir

vapendavir · Altesa Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Vapendavir, covering 2018-05-07 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection [Phase 2]